International Journal of Inflammation, Cancer and Integrative Therapy
The Okayama Lung Cancer Study Group Experience: A Comparison of the Incidence and Pattern of Interstitial Lung Disease during Erlotinib and Gefitinib Treatment in Japanese Patients with Non-Small Cell Lung Cancer
